Associate Professor, Oncology, Mayo Medical School

Oncology

Gary Croghan works in the field of Oncology. He attended University at Buffalo, School of Medicine and Biomedical Sciences. Gary Croghan has written publications. He has 48 publications published with PubMed. The lastest paper is: 'Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms.'

Publications

---

• Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
• Phase 1 study of sorafenib in combination with bortezomib in patients with advanced Malignancies.
• Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.
• Fluctuation of Systemic immunity in melanoma and implications for timing of therapy.
• Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung Cancer treated with chemotherapy.
• A 51-year-old man with rapidly progressive metastatic sarcomatoid renal cell Carcinoma: an apparent complete clinical response to second-line therapy with sunitinib an...
• A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant Melanoma: a phase 2 consortium study.
• Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States.
• Second primary tumors following tobacco dependence treatments among head and neck Cancer patients.
• A phase II study of ABT-510 (thrombospondin-1 Analog) for the treatment of metastatic melanoma.
• Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
• A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell Carcinoma.
• Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic Melanoma.
• Effects of biochemically confirmed smoking cessation on white blood cell count.
• A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced Cancer.
• A contest to create media messages aimed at recruiting adolescents for stop smoking programs.
• Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate Cancer: a Phase 2 trial.
• Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair Analysis.
• A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced Cancer.
• Tobacco use outcomes among patients with lung Cancer treated for nicotine dependence.
• Colorectal Cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapy.
• A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal Cancer.
• Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung Cancer.
• Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung Cancer: contemporary experience from a single institution.
• Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced Cancer.
• Prostate-specific antigenic domain of human Prostate specific antigen identified with monoclonal antibodies.
• Heterotransplantation of human prostatic tissue.
• A community-wide smoking cessation program: Quit and Win 1998 in Olmsted county.
• Endoscopic technique with ultrasound imaging for neurolytic celiac plexus block.
• Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.
• Carbidopa/levodopa for smoking cessation: a pilot study with negative results.
• Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.
• A randomized trial of naltrexone for smoking cessation.
• Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian Cancer.
• Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms.
• Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
• Cell and tumor markers'' immunohistochemistry in transitional cell carcinoma of the Bladder.
• Prognostic factors in bladder Cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study.
• Malignant phyllodes tumor of Prostate.
• Prediction of prognosis in primary breast Cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer...
• Prognostic factors in survival of bladder Cancer.
• Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in...
• Environmental tobacco smoke exposure in women with lung Cancer.
• The prevalence of weight concerns in a smoking abstinence clinical trial.
• A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients wi...
• Do patients with schizophrenia receive state-of-the-art lung Cancer therapy? A brief report.
• Perivascular epithelioid cell neoplasm of the uterine cervix: an unusual tumor in an unusual location.

Schools

---

• Roswell Park Canc Institute

• Kaleida Health Sys M Fillmore

• Mayo Grad School MedMayo Fndn

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

• Choice Plus POS II
• Great West Healthcare-Cigna PPO
• MultiPlan PPO
• PHCS Network PPO

Education

---

• Mayo School of Graduate Medical Education
• University at Buffalo, School of Medicine and Biomedical Sciences

Hospital

---

• Mayo Clinic - Rochester, Minnesota

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Andrea E. Wahner Hendrickson, MD This Doctor is OpenDoctor Recommended.
	Dr. Harry H. Yoon, MD This Doctor is OpenDoctor Recommended.
	Dr. Randolph S. Marks, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Paul Haluska Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Arif H. Kamal, MD This Doctor is OpenDoctor Recommended.
	Dr. James N. Ingle, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Matthew P. Goetz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Robert B. Diasio, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Morris A. Gertz

---

Doctor Directory | TOS | twitter | FB | Angel | blog